StageZero Life Sciences Ltd.
SZLS.TO
TSX
09/30/2024 | 06/30/2024 | 03/31/2024 | 09/30/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 15.00K | 20.70K | 5.50K | 24.10K | 24.10K |
Total Receivables | 92.70K | 138.80K | 96.30K | 82.30K | 82.30K |
Inventory | 52.20K | 22.60K | 22.60K | 22.60K | 22.60K |
Prepaid Expenses | 75.20K | 43.30K | 59.40K | 165.60K | 165.60K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 235.00K | 225.40K | 183.70K | 294.50K | 294.50K |
|
|||||
Total Current Assets | 235.00K | 225.40K | 183.70K | 294.50K | 294.50K |
Net Property, Plant & Equipment | 345.70K | 358.30K | 195.70K | 213.90K | 213.90K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 580.70K | 583.70K | 379.50K | 508.40K | 508.40K |
|
|||||
Total Accounts Payable | 3.98M | 3.88M | 3.93M | 3.67M | 3.67M |
Total Accrued Expenses | 5.11M | 4.88M | 4.15M | 3.77M | 3.77M |
Short-term Debt | 966.10K | 905.00K | 844.30K | 497.70K | 497.70K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 165.30K | 191.40K | 120.00K | 120.00K | 120.00K |
Total Finance Division Other Current Liabilities | 105.00K | 104.50K | 127.50K | 214.50K | 214.50K |
Total Other Current Liabilities | 105.00K | 104.50K | 127.50K | 214.50K | 214.50K |
Total Current Liabilities | 10.33M | 9.96M | 9.17M | 8.27M | 8.27M |
|
|||||
Total Current Liabilities | 10.33M | 9.96M | 9.17M | 8.27M | 8.27M |
Long-Term Debt | 873.50K | 838.40K | 804.60K | 741.00K | 741.00K |
Short-term Debt | 966.10K | 905.00K | 844.30K | 497.70K | 497.70K |
Capital Leases | 128.80K | 144.60K | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 378.00K | 378.00K | 605.00K | 571.90K | 571.90K |
Total Liabilities | 11.71M | 11.32M | 10.58M | 9.58M | 9.58M |
|
|||||
Common Stock & APIC | 115.17M | 115.16M | 115.75M | 115.74M | 115.74M |
Retained Earnings | -127.53M | -127.13M | -127.19M | -126.05M | -126.05M |
Treasury Stock & Other | 1.23M | 1.23M | 1.23M | 1.23M | 1.23M |
Total Common Equity | -11.13M | -10.74M | -10.20M | -9.07M | -9.07M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -11.13M | -10.74M | -10.20M | -9.07M | -9.07M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -11.13M | -10.74M | -10.20M | -9.07M | -9.07M |
|